June 2026– date –
-
CCRM, OmniaBio, and Avectas Partner to Enhance Cell Therapy Manufacturing with Automated Platform Evaluation
BioSpace Canada Overview CCRM and its CDMO subsidiary, OmniaBio Inc., have partnered with Avectas Limited to evaluate an automated, integrated, and scalable cell therapy manufacturing platform. This collaboration aims to explore how Avec... -
Orca Bio Boosts East Coast Manufacturing Capacity, Triples West Coast Workforce Ahead of Potential Orca-T® Launch
BioSpace USA Overview Orca Bio announced the expansion of its East Coast manufacturing capacity and a threefold increase in its West Coast manufacturing workforce, in anticipation of the potential launch of its flagship program, Orca-T®.... -
Distek Unveils BIOne Core Software: A Cloud-Based SaaS Solution for Streamlined Bioprocess Historical Data Management
Labcompare.com USA Overview Distek has launched 'BIOne Core Software,' a cloud-based historical data software platform designed exclusively for BIOne Bioprocess Controllers, offered as a SaaS solution. This software enables users to easi... -
NTHRYS Accelerates Bioprocess Development with AI-Powered DoE Automation: Integrating Media Optimization, Scale-Up, and IoT Parameter Control
NTHRYS India Overview NTHRYS Biotech Labs is accelerating bioprocess development through AI-powered Design of Experiments (DoE) automation solutions. These include machine learning tools for predicting optimal media composition and autom... -
BioProcess International Reports on Mesenchymal Stem Cell (MSC) Large-Volume Manufacturing Challenges and Corning HYPERStack™ Contribution
BioProcess International USA Overview BioProcess International reported on the challenges and progress in large-volume manufacturing of mesenchymal stem cells (MSCs). The approval of two iPSC-derived therapies in Japan indicates growing ... -
New Market Pitch Evaluates Top Cell Therapy Startups Including Orca Bio, Cellares, and Kelonia: Differentiated by Clinical, Manufacturing, and Strategic Advancements
New Market Pitch USA Overview New Market Pitch selected ten leading cell therapy startups—Orca Bio, Kyverna, Cabaletta Bio, Cellares, Immatics, Iovance, Sana, Kelonia, Orna, and Dispatch Bio—evaluating their regulatory maturity, clinical... -
Cellbase Emphasizes Critical Role of Real-Time Monitoring Tools for Bioreactor Scale-Up
Cellbase Germany Overview Cellbase highlighted the imperative of integrating real-time monitoring tools for successful bioreactor scale-up. As bioreactor scale increases, single-point monitoring becomes inadequate, leading to mixing dela... -
VIVEbiotech Reaches 15 In Vivo Lentiviral Vector Programs, Fortifying Gene Therapy Manufacturing Leadership
BioPharma BoardRoom スペイン Overview VIVEbiotech has significantly advanced its position in gene therapy manufacturing by adding its 15th in vivo lentiviral vector (LVV) therapeutic program. This milestone underscores the company's robu... -
Nkarta Accelerates Clinical Development of Off-the-Shelf NK Cell Therapies NKX019 and NKX101 from Healthy Donors
Umbrex USA Overview Nkarta, a clinical-stage biotechnology company, focuses on off-the-shelf natural killer (NK) cell therapies, utilizing a platform that genetically engineers and cryopreserves healthy donor-derived NK cells. Its lead p... -
Pharma 4.0 Drives Digital Integration: LIMS, AI, and Digital Twins Revolutionize Pharmaceutical Manufacturing
Technology Networks UK Overview Pharma 4.0 is advancing digital integration, leveraging LIMS, AI algorithms, and digital twin technology to eliminate data silos and foster connected pharmaceutical manufacturing. Digital twins extend the ...
